The often-slow and complex process of clinical trial recruitment, a critical bottleneck in bringing new treatments to market, is getting an AI-driven overhaul. TrialClinIQ, a platform designed to accelerate patient enrollment, has secured $150K in pre-seed funding to advance its mission.
The company leverages artificial intelligence to intelligently match diverse, eligible candidates to relevant studies, aiming to streamline a process that frequently delays research timelines and limits participant diversity. This early investment signals confidence in TrialClinIQ's approach to a long-standing industry challenge.
.png&w=3840&q=75)
